A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment
MetadataShow full item record
CitationDemirbaş, A., Elmas, Ö. F., Atasoy, M., Türsen, Ü., & Lotti, T. (2020). A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment. Dermatologic Therapy.
Dear Editor, In December 2019, the cases of pneumonia of unknown etiology were reported in Wuhan city, Hubei province of China. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, a novel coronavirus, was detected from the lower respiratory tract samples of infected patients, and this virus-caused respiratory tract infection was termed Coronavirus Disease 2019 (COVID-19). The pandemic was declared by World Health Organization on 11 March 2020 and as of 21 May 21 2020, more than 5 million cases and more than 300 thousand deaths were reported.1 The disease has been reported to show different types of cutaneous findings including urticarial, maculopapular, erythema multiforme-like, varicella-like, purpuric, livedoid, and thrombotic-ischemic lesions.2, 3 Given the high mortality rate of the disease, prompt and accurate identification of the relevant skin manifestations may play a significant role in the early diagnosis and appropriate management of the entity...